Remove Develop Remove Marketing Remove Sales Remove Thousand Oaks
article thumbnail

Nexsan Names Sales Head

socalTECH

Thousand Oaks-based Nexsan, a developer of storage hardware products, has appointed a new Chief Commercial Officer, the firm disclosed Monday. Nexsan said that Michael McGuire has joined the firm, reporting to CEO Philip Black, and will be in charge of worldwide sales, marketing, and business development.

Sales 100
article thumbnail

Xirrus Adds Calix CEO Russo To Board

socalTECH

Thousand Oaks-based Xirrus , the developer of wireless networking equipment headed by Dirk Gates, has snagged the CEO of networking equipment maker Calix for its board. At Xircom, Russo was COO and responsible for sales, marketing, development, and manufacturing. READ MORE>>.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Xirrus In Channel Expansion Effort

socalTECH

Thousand Oaks-based Xirrus , the developer of Wi-Fi access arrays, looks to be a big channel expansion push, saying Thursday that it has expanded its partnership program in Europe, for the enterprise, as well as for schools and universities. Concurrently, the firm said it launched a new enterprise partner program in the U.S.,

article thumbnail

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

Two days later, it paid AstraZeneca $550 million upfront for the rights to a group of antibiotics either already on the market or in late-stage testing. The deal also includes a $175 million deferred payment due in 2019 and $850 million in downstream payouts tied to regulatory and sales targets. Morgan party.

Pricing 40
article thumbnail

Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More

Xconomy

Then came the rumor mill: Companies may or may not be approaching Biogen about a sale, and Biogen may or may not be fielding offers. Instead, Holmes promoted a new system, MiniLab , in development. As a result, Biogen will buy the rights to nusinersen and prepare to ask regulators for marketing approval.

News 40